Navigation Links
Par Pharmaceutical Begins Shipment of Budesonide Inhalation Suspension Immediately
Date:11/19/2008

WOODCLIFF LAKE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has entered into a supply and distribution agreement with AstraZeneca in the U.S. to market budesonide inhalation suspension, which is a generic form of AstraZeneca's Pulmicort Respules(R) indicated for the maintenance treatment of asthma. Par began shipping 0.25 mg/2 ml and 0.5 mg/2 ml to the trade today.

Full-year US sales for PULMICORT(R) in 2007 totalled $964 million, about 90 percent of which is accounted for by PULMICORT RESPULES(R).

Important information about budesonide inhalation suspension

Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age.

Budesonide inhalation suspension is not indicated for the relief of acute bronchospasm.

Budesonide inhalation suspension is contraindicated as the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. Hypersensitivity to budesonide or any of the ingredients of this preparation contraindicates the use of budesonide inhalation suspension.

Please read full prescribing information available at www.parpharm.com/products.

About Par Pharmaceutical Par Pharmaceutical, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit www.parpharm.com.

Safe Harbor Statement

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securi
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
2. Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics, According to Ernst & Young Report
3. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
4. KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q
5. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
6. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
7. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
8. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
9. Radiopharmaceutical Cardiolite has 15 Percent More Market Share than Myoview for September 2008
10. Irvine Pharmaceutical Services Introduces New Fill-and-Finish Subsidiary
11. KV Pharmaceutical to File Form 12b-25 on November 12, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...isk continues for 12 weeks and includes minimally ...RSDAY, Dec. 3 (HealthDay News) -- Potentially fata...k than has previously been thought, a British stud...nly is the risk higher, but that it lasts much lon..., a clinical epidemiologist at the University of O...
(Date:12/3/2009)... Economic downturn causes ...ams. Mountainside in Connecticut cites a sharp inc...ress caused by economic crisis which has led to an...and marital problems. , (... Addiction Treatment Center sees a huge spike in d...
(Date:12/3/2009)..., , LONDON, Dec. 3 Chil...inical research organization (CRO) providing clini...he Americas and Asia, today announces the appointm...ent, Global Quality & Medical Affairs. Dr. Moo...office. ,, Dr. Moore is a physician with 15 yea...
(Date:12/3/2009)..., , SARASOTA, Fla., Dec. 3 /PRNewswire/ ... documentary, get ready for a stunning look at the...aker Jenna Norwood will screen her feature documen...versity on Tuesday, December 8th, 5 p.m. at Sever ... "Supercharged Living" College Tour. The film will...
(Date:12/3/2009)...ithout need to fly far for food, wing shapes chang..., Dec. 3 (HealthDay News) -- Many people think evo... but it can happen much faster and new research sh...n winter appears to be having an effect on a popul...r findings in the Dec. 3 online edition of Curren...
Breaking Medicine News(10 mins):Health News:Blood Clot Threat After Surgery Worse Than Thought 2Health News:Blood Clot Threat After Surgery Worse Than Thought 3Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2Health News:Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs 2Health News:Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University 2Health News:Feeding Birds in Winter Could Speed Evolution of Species 2
... Alzheimer,s researchers have co-edited a book cri... the diagnosis and treatment of Alzheimer,s diseas...rence held in Chile, George Perry, dean of the Col...ol have edited " Current Hypotheses and Research M...
... and Washington DC (May 29, 2009) Those in the Un...o use marijuana than those in Kenya, South Africa ...ing to a new study published in Clinical Nursing ...ommon symptoms, once again raising the issue that ...
...PRA International, a leading Clinical Research Org...ted an Oncology audioconference and announces it w...al Oncology (ASCO) meeting in Orlando, Florida, Ma... Scientific Affairs, Statistical Consulting - Onco...
...r Institute (JCVI) announced today that they have ...m the National Institute of Allergy and Infectious... of Health, as one of their Genomic Sequencing Cen...e JCVI to continue to expand its decades-long expe...
...e some unique health issues , , MINNEAPOLIS/ST. P...pected to go to school this fall as a result of th...l need to ensure student veterans, unique needs ar...versities (MnSCU). , , The report, "Health and H...
... and Washington DC (May 29, 2009) The FDA is ignor...prove an over-the-counter, rapid HIV test for home... Medical Decision Making ( MDM ) which is publis...rd it. The FDA has been criticized because it bas...
Other Medicine News:Health News:UTSA Dean George Perry co-edits textbook chronicling four decades of Alzheimer's research 2Health News:Marijuana rivals mainstream drugs for HIV/AIDS symptoms 2Health News:Marijuana rivals mainstream drugs for HIV/AIDS symptoms 3Health News:PRA International Oncology Experts at ASCO 2Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 2Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 3Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 3Health News:FDA ignores critical information on home HIV tests 2
(Date:12/3/2009)... Texas, Dec. 3 ULURU In...dical-Surgical, Inc., one of the major pharmaceuti...d ULURU Inc. to be one of its suppliers and has pl.... McKesson Medical-Surgical delivers a comprehensi...equipment and health care technology-related servi...
(Date:12/3/2009)..., Mich., Dec. 3 Pioneer Surgical T...tive medical devices, received 2 awards in the Cer...logy Awards gala held recently in San Francisco, C...pine Society annual meeting. ,, Pioneer Surgica...were the NuNec® Cervical Total Disc replaceme...
(Date:12/3/2009)... GROVE, Minn., Dec. 3 Upsher-Smith... of its strategic plan for central nervous system ...amate), an internally developed program for the ma...th Upsher-Smith,s proprietary formulation technolo...rly 2010 for the adjunctive treatment of epilepsy ...
Breaking Medicine Technology:ULURU Inc. Obtains Status of Approved Supplier With McKesson. 2Pioneer(R) Surgical Technology, Inc. Receives Prestigious Spine Technology Awards 2Upsher-Smith Announces Milestone in Development of CNS Strategy 2HIMSS Electronic Health Record Association Elects New Leadership 52251 1HIMSS Electronic Health Record Association Elects New Leadership 52251 2HIMSS Electronic Health Record Association Elects New Leadership 52251 3Community Hospitals 3A Dying Breed or Community Cornerstone 3F 52248 1Community Hospitals 3A Dying Breed or Community Cornerstone 3F 52248 2International Isotopes Inc Announces Results of the Annual Meeting and Provides an Update on its Depleted Uranium Processing and Fluorine Extraction 52245 1International Isotopes Inc Announces Results of the Annual Meeting and Provides an Update on its Depleted Uranium Processing and Fluorine Extraction 52245 2International Isotopes Inc Announces Results of the Annual Meeting and Provides an Update on its Depleted Uranium Processing and Fluorine Extraction 52245 3International Isotopes Inc Announces Results of the Annual Meeting and Provides an Update on its Depleted Uranium Processing and Fluorine Extraction 52245 4
...Urological Association Annual Meeting -- , , SEAT...on Corporation (Nasdaq: DNDN ) today presented p...263, Dendreon,s orally bioavailable small molecule...nel protein), to treat benign prostatic hyperplasi...e BPH alone and in combination with finasteride, a...
...il 28 Debiopharm Group,(Debiopharm), a global bio...,on serious medical conditions, particularly in th... IIa study with Debio 025, a selective,cyclophilin...CV) effect.,Revealed at the 44th Annual Meeting of...er, in Copenhagen, these findings showed potent an...
Other Medicine Technology:Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia 2Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia 3Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia 4Clinical Update - Debio 025 in Hepatitis C 2Clinical Update - Debio 025 in Hepatitis C 3
...a powerful automated system capable of handling an...from 6 user-programmable test protocols to begin a...ny tests not included in the comprehensive list of...oppler, PVR and PPG instrument modes. Provides hig...
CD Horizon M10
Silhouette
...Fixation System combines the flexibility of polyax...rs into a single system. The result is a construc...ng to the vertebral anatomy, thus reducing potenti...ial screws and lateral connectors reduces the pote...
Medicine Products: